This pharmaceutical company specializes in a patented sublingual drug-delivery system designed for opioid cessation and non-addictive pain management solutions. By integrating proprietary technology with manufacturing and distribution capabilities, the company aims to provide effective alternatives to traditional opioid treatments.
Funding
$3.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional opioid treatments for pain management and cessation often lead to addiction and adverse side effects, creating a need for safer and more effective alternatives. Existing drug delivery methods may also result in inconsistent absorption and delayed therapeutic effects.
Solution
Vivera Pharmaceuticals is a biopharmaceutical and medtech company focused on providing innovative solutions for opioid cessation and non-addictive pain management. The company utilizes its patented TABMELT sublingual drug delivery system to administer pharmaceutical compounds, allowing for faster and more consistent absorption compared to traditional oral methods. Vivera's vertically integrated structure encompasses technology, biosciences, medical devices, and advanced diagnostics divisions, enabling it to develop and distribute a range of therapies and medical devices. In addition to sublingual drug delivery, Vivera develops intelligent, dose-controlled electronic prescription dispensing devices like ZICOH and portable telemedicine stations such as MDZone.
Target Audience
Vivera Pharmaceuticals primarily serves patients seeking non-addictive pain management and opioid cessation solutions, as well as healthcare providers looking for innovative drug delivery systems and medical devices.
Features
- Patented TABMELT sublingual drug delivery system for rapid and consistent absorption
- ZICOH: Intelligent, dose-controlled electronic prescription dispensing device
- MDZone: Portable telemedicine station for remote patient monitoring and consultations
- Development of pharmaceutical treatments for cardiovascular and central nervous system conditions, and fluency disorders
- LabPort: A Lab Information Management System (LIMS) that streamlines laboratory testing and results reporting
- Concierge testing services via Metriks Diagnostics